首页> 外文期刊>Yangtze Medicine >The Application of Quantum Dots Double-Labeling Immunofluorescence Technology in Detection of PR and CD146 in Paraffin-Embedded Tissue Sections of Endometrioid Adenocarcinoma
【24h】

The Application of Quantum Dots Double-Labeling Immunofluorescence Technology in Detection of PR and CD146 in Paraffin-Embedded Tissue Sections of Endometrioid Adenocarcinoma

机译:量子点双标签免疫荧光技术在子宫内膜样腺癌石蜡包埋组织切片中PR和CD146检测中的应用

获取原文
           

摘要

Objective: The aim was to detect the expression of PR and CD146 in paraf-fin-embedded tissue sections of endometrioid adenocarcinoma by using QDs double-labeling immunofluorescence, and evaluate the applied value of QDs double-labeling immunofluorescence in endometrioid adenocarcinoma. Methods: To detect the expression of PR and CD146 on 140 cases of paraffin-embedded tissue sections of endometrioid adenocarcinoma by using QDS double-labeling immunofluorescence. Results: The co-expression of PR and CD146 in the endometrioid adenocarcinoma can be detected by QDs double-labeling immunofluorescence, and there was no correlation between them (P > 0.05). Conclusion: QDs double-labeling immunofluorescence can detect the localization and co-expression of PR and CD146 in the endometrioid adenocarcinoma.
机译:目的:利用QDs双标记免疫荧光法检测子宫内膜样腺癌旁鳍组织切片中PR和CD146的表达,并评价QDs双标记免疫荧光法在子宫内膜样腺癌中的应用价值。方法:采用QDS双标记免疫荧光法检测140例子宫内膜样腺癌石蜡包埋组织中PR和CD146的表达。结果:通过QDs双标记免疫荧光可以检测PR和CD146在子宫内膜样腺癌中的共表达,且两者之间没有相关性(P> 0.05)。结论:QDs双标记免疫荧光可以检测子宫内膜样腺癌中PR和CD146的定位和共表达。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号